z-logo
open-access-imgOpen Access
Propagation of prions causing synucleinopathies in cultured cells
Author(s) -
Amanda L. Woerman,
Jan Stöhr,
Atsushi Aoyagi,
Ryan Rampersaud,
Zuzana Krejciova,
Joel C. Watts,
Takao Ohyama,
Smita S. Patel,
Kartika Widjaja,
Abby Oehler,
David W. Sanders,
Marc I. Diamond,
William W. Seeley,
Lefkos Middleton,
Steve Gentleman,
Daniel A. Mordes,
Thomas C. Südhof,
Kurt Giles,
Stanley B. Prusiner
Publication year - 2015
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.1513426112
Subject(s) - progressive supranuclear palsy , synucleinopathies , dementia with lewy bodies , atrophy , pathology , biology , disease , medicine , alpha synuclein , parkinson's disease , dementia
Increasingly, evidence argues that many neurodegenerative diseases, including progressive supranuclear palsy (PSP), are caused by prions, which are alternatively folded proteins undergoing self-propagation. In earlier studies, PSP prions were detected by infecting human embryonic kidney (HEK) cells expressing a tau fragment [TauRD(LM)] fused to yellow fluorescent protein (YFP). Here, we report on an improved bioassay using selective precipitation of tau prions from human PSP brain homogenates before infection of the HEK cells. Tau prions were measured by counting the number of cells with TauRD(LM)-YFP aggregates using confocal fluorescence microscopy. In parallel studies, we fused α-synuclein to YFP to bioassay α-synuclein prions in the brains of patients who died of multiple system atrophy (MSA). Previously, MSA prion detection required ∼120 d for transmission into transgenic mice, whereas our cultured cell assay needed only 4 d. Variation in MSA prion levels in four different brain regions from three patients provided evidence for three different MSA prion strains. Attempts to demonstrate α-synuclein prions in brain homogenates from Parkinson's disease patients were unsuccessful, identifying an important biological difference between the two synucleinopathies. Partial purification of tau and α-synuclein prions facilitated measuring the levels of these protein pathogens in human brains. Our studies should facilitate investigations of the pathogenesis of both tau and α-synuclein prion disorders as well as help decipher the basic biology of those prions that attack the CNS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom